Shocking Increase In Antimicrobial Resistance For Common Urinary Tractact Infection Drug

Five Fold Increase in Ciprofloxacin (UTI drug) Resistance

In a surveillance study of over 12 million bacteria, investigators at The George Washington University and Providence Hospital found E. coli antimicrobial resistance to ciprofloxacin, the most commonly prescribed antimicrobial for urinary tract infections in the U.S., increased over five-fold from 2000 to 2010. In addition, nearly one in four isolates in 2010 were resistant to trimethoprim-sulfamethoxazole (Bactrim®), the second most commonly prescribed drug for this infection. This research was published in the April edition of the journal, Antimicrobial Agents and Chemotherapy.

More Expensive Drugs are on Their Way

“Our study is important because it shows that E. coli resistance to two common drugs to treat UTIs rose substantially over the last decade. For patients, this will ultimately translate into more expensive and sometimes more complex antimicrobial treatments. What is more concerning however, is the lack of new antimicrobial drug development which has been declining for decades,” said Guillermo Sanchez, a graduate student in the Physician Assistant program at the George Washington University and primary author of the study.

E. coli accounts for 75% to 95% of urinary tract infections (UTIs) and UTIs are among the most common infections in humans, with half of all women experiencing at least one in their lifetime. E. coli antimicrobial resistance is a major factor in determining health outcomes in patients with UTIs. E. coli antimicrobial resistance has been associated with lower likelihood of clinical cure and increased risk of infection recurrence. Additionally, antimicrobial resistance significantly increases patient morbidity, costs of treatment, and rates of hospitalization.

As antimicrobial resistance continues to increase, remaining antimicrobial drug options have a higher likelihood of causing unwanted side effects such as gastrointestinal distress, nausea, and vomiting. Due to a lack of drug development, the paucity of new antimicrobial drugs for common infections like UTIs will continue to worsen in the near future.

Who uses Colloidal Silver?

An estimated 10 million Americans consume colloidal silver daily. Uses range from general health, routine household germ elimination, water purification, to treatment for ailments such as Lyme, Candida and yeast infections, MRSA and Morgellons.

Common Uses for Colloidal Silver

Used correctly, colloidal silver is an effective antimicrobial. Use NutraSilver® Plus to support a healthy immune system, disinfect surfaces and purify water. See NutraSilver® customer-suggested uses here.

Barbara       March 2012

“Just wanted to let your know my mother has been taking the [NutraSilver] drops since November [for Morgellons] and has had amazing changes.  She said she hasn’t felt this good in years.  The lesions on her legs have gone away and it looks like bruises.”

You deserve to be healthy. 

We offer free telephone consultations, so please call our toll-free number (888) 240-2326 option #2  PST

Advertisements

About CareMan
I am the CareMan, have been for 7 years now. I really do care about YOU and getting YOU back to great, natural health, so long as you have an open mind.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: